| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/21/2026 | ±3.9% | +2.4% | over-priced |
| 04/22/2026 | ±3.4% | -0.4% | over-priced |
| 01/28/2026 | ±2.9% | -0.5% | over-priced |
| 10/22/2025 | ±2.4% | -1.1% | over-priced |
| 07/23/2025 | ±3.0% | +1.5% | over-priced |
| 04/23/2025 | ±3.5% | +2.5% | over-priced |
| 01/29/2025 | ±1.9% | -1.1% | over-priced |
| 10/23/2024 | ±2.5% | -1.6% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $14.77 | $4.9B | $920M |
| Q1 FY2026 | $8.43 | $4.0B | $531M |
| Q4 FY2025 | $10.27 | $4.2B | $653M |
| Q3 FY2025 | $10.91 | $4.2B | $701M |
URI (URI) reports in 107 days, with the next report estimated for 02/11/2027. Across the last 8 reports, options priced an average ±2.9% earnings move while the stock actually moved 1.4% on average — the market has systematically over-priced URI's earnings risk. Fundamentals into the print: EPS up 35.4% year-over-year, revenue up 15.7%. QuantLogix's live 5-factor engine currently reads URI as a buy at 69/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →